HLA class I immune editing in JAK2 V617F and CALR exon 9 mutation driven myeloproliferative malignancies

被引：0
|
作者：
Ivanova, Milena [1 ]
Tsvetkova, Gergana [2 ]
Micheva, Iliana [3 ]
Lessichkova, Spaska [1 ]
Petrova, Zasmina [4 ]
Ivanova, Anela [4 ]
Madjarova, Galja [4 ]
Hadjiev, Evgueniy [2 ]
Shivarov, Velizar [5 ]
机构：
[1] Med Univ, Univ Hosp Alexandrovska, Dept Clin Immunol, Sofia, Bulgaria
[2] Med Univ, Univ Hosp Alexandrovska, Dept Clin Hematol, Sofia, Bulgaria
[3] Med Univ, Univ Hosp Sveta Marina, Clin Hematol, Varna, Bulgaria
[4] Sofia Univ St Kl Ohridski, Fac Chem & Pharm, Dept Phys Chem, Sofia, Bulgaria
[5] Med Univ Pleven, Dept Expt Res, Pleven, Bulgaria
来源：
HLA | 2023年 / 101卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P2
引用
收藏
页码：366 / 367
页数：2
相关论文
共 50 条
  • [1] A Case Report on Coexisting JAK2 V617F and Calr exon 9 Mutation in Essential Thrombocythemia
    Rashid, Munazza
    Ahmed, Rifat Zubair
    Ahmed, Shariq
    Nadeem, Muhammad
    Ahmed, Nuzhat
    Shamsi, Tahir
    BLOOD, 2015, 126 (23)
  • [2] Development of a PCR Assay for Detection of JAK2 Exon 14 (V617F), JAK2 Exon 12 and CALR Exon 9 Mutations in Myeloproliferative Disorders
    Maxwell, D. C.
    Grenier, S.
    Nwachukwu, B.
    Jensen, M.
    Morrison, W.
    Stockley, T. L.
    Karnel-Reid, S.
    Wei, C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 959 - 959
  • [3] JAK2 V617F mutation and the myeloproliferative disorders
    Vainchenker, William
    Casadevall, Nicole
    HEMATOLOGIE, 2006, 12 (01): : 3 - 7
  • [4] The JAK2 V617F mutation in the myeloproliferative disorders
    Sale, MA
    Awan, A
    Lucas, GS
    Yin, JAL
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 33 - 33
  • [5] The V617F JAK2 mutation and the myeloproliferative disorders
    Percy, MJ
    McMullin, MF
    HEMATOLOGICAL ONCOLOGY, 2005, 23 (3-4) : 91 - 93
  • [6] HLA class II immune editing in JAK2V617 and CALR mutation driven oncogenesis
    Ivanova, Milena
    Tsvetkova, Gergana
    Tsvetelin, Lukanov
    Micheva, Iliana
    Hadjiev, Evgueniy
    Shivarov, Velizar
    HLA, 2022, 99 (05) : 449 - 449
  • [7] JAK2 (V617F) mutation in patients with chronic myeloproliferative disorders
    Hamidah, N.
    Farisah, N.
    Jalil, N.
    Fei-Liang, W.
    AWahid, F.
    Othman, A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 121 - 122
  • [8] Coexistence of lymphoproliferative and myeloproliferative neoplasms with simultaneous CALR and JAK2 V617F mutations
    Yang, Hai-Su
    CANCER BIOMARKERS, 2016, 17 (04) : 383 - 389
  • [9] Rapid detection of JAK2 V617F mutation in myeloproliferative disorders
    Mir, Rashid
    AbuDuhier, Faisal M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [10] 2 DIFFERENT PHENOTYPES IN ESSENTIAL THROMBOCYTHEMIA: MUTATION JAK2 V617F OR CALR
    Vilches Moreno, A. S.
    Guerrero Fernandez, L.
    Latorre Gonzalez, A.
    Monteagudo Saiz, D.
    Robles Marina, V
    Andreu Costa, A.
    Ayala Diaz, R.
    Martinez Lopez, J.
    HAEMATOLOGICA, 2016, 101 : 187 - 187
12345